We are eager to join the Dutch life sciences conference – a great opportunity for high-quality networking with many start-up companies, service providers, and research organisations.
This year we are happy to be showcasing our novel InnoSer Acceleration Program (ISAP) and our comprehensive and flexible service offering in-vitro and in-vivo.
With a footprint in the Netherlands and in Belgium, InnoSer’s facilities are especially well equipped to support its regional colleagues in the field struggling with the setup or expansion of their research pipelines either in-vitro or in-vivo. With our expert staff and well-equipped labs and facilities, we’re able to support your company at any step along the way.
As such, the goal of the ISAP program is to provide our (local) partners with facilities, expert support, state-of-the-art equipment and other essential tools to help you expand your research pipelines. We are eager to collaborate and tailor our services to meet your scientific needs and support you in reaching your goals. Whether this requires offboarding your research to be executed by our expert staff or whether you’d require support for a very specific need, e.g., the maintenance of your valuable in-vivo research models, allowing you to focus on your in-house research. We’re ready with a solution to fit your needs.
Together with our partners, ISAP helps us to pursue our ambition; creating a smart road to better health.
Here’s a glimpse of the services that you may benefit from.
- Access to unique research models, such as Patient-derived xenografts and Polycystic kidney disease models
- IACUC and veterinary support
- Safety, tolerability and toxicology
- PK/PD studies
- Animal and supply management
- Dosing and animal handling
- Tissue and organ dissections
- Cryopreservation
- Necropsy
- Surgery
Additional support and guidance:
- Scientific support
- Analysis and interpretation of data
- Study preparation
- Access to our in vivo analysis systems
Get in touch with Pascal Simoens at the Dutch Life Sciences conference to hear more about the full scope of our ISAP program. If you are curious, you can already read about the introduction to the ISAP program at Innovation for Health here. We will see you soon!
Curious about more information on our ISAP program?
Contact our expert Pascal for an outline of the program possibilities for your upcoming project.
Want to read more?
Novel Translational Readout: Auditory Event-Related Potentials EEG-Recording in Fragile X Syndrome Model
Fragile X Syndrome Fragile X syndrome is caused by mutations of the FMR1 gene, leading to loss of functional fragile x mental retardation protein (FMRP). FXS is characterised by delays in neurodevelopmental milestones, autistic behaviour, anxiety, and cognitive...
Accelerating ALS Drug Development: InnoSer’s Available In Vivo Models for Preclinical Research
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder lacking highly effective disease-modifying treatment or a cure. The often-heterogenous course of ALS underlines the need for modelling the different disease aspects in multiple, distinct models...
In Vitro & In Vivo Parkinson’s Disease Models: Understanding Their Role in Preclinical Drug Development
Parkinson’s disease (PD) is a complex neurodegenerative disorder that affects millions of people worldwide. Different experimental models recapitulate distinct pathophysiological features of PD. Selecting the most appropriate model for a specific research question is...